Literature DB >> 3746584

Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions.

F C Odds, A B Abbott, G Pye, P F Troke.   

Abstract

Low, reproducible minimal inhibitory concentrations against Candida species, with sharp, precise end points in complex media were achieved for imidazoles (clotrimazole, econazole, miconazole, tioconazole and ketoconazole) and triazoles (fluconazole, itraconazole, vibunazole, ICI 153066) by including in the test medium antibacterial antibiotics that bind to the 80S eukaryotic ribosome and inhibit protein synthesis, i.e. blasticidin, cycloheximide, doxycycline, neomycin and gentamicin. The presence of these antibiotics reduced MICs, on average, by 50- to 250-fold. Other protein synthesis inhibitors (rifampicin, erythromycin, lincomycin, clindamycin, chloramphenicol and fusidic acid) were not effective, and the antibiotics did not affect MICs for Aspergillus species. The low azole MICs were in close agreement with MICs obtained in a defined, tissue culture-based medium lacking added antibiotics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746584     DOI: 10.1080/02681218680000461

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  15 in total

Review 1.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

2.  Improved method for azole antifungal susceptibility testing.

Authors:  M A Gordon; E W Lapa; P G Passero
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 3.  In vitro and in vivo evaluation of antifungal agents.

Authors:  A Espinel-Ingroff; S Shadomy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 4.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 5.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.

Authors:  O Marchetti; P Moreillon; M P Glauser; J Bille; D Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Comparative efficacy of amphotericin B, clotrimazole and itraconazole against Aspergillus spp. An in vitro study.

Authors:  Y H Hahn; D G Ahearn; L A Wilson
Journal:  Mycopathologia       Date:  1993-09       Impact factor: 2.574

8.  Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing.

Authors:  R Guinet; D Nerson; F de Closets; J Dupouy-Camet; L Kures; M Marjollet; J L Poirot; A Ros; J Texier-Maugein; P J Volle
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

9.  Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.

Authors:  R A Fromtling; J N Galgiani; M A Pfaller; A Espinel-Ingroff; K F Bartizal; M S Bartlett; B A Body; C Frey; G Hall; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

10.  Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi.

Authors:  Brian G Oliver; Peter M Silver; Chelsea Marie; Samantha J Hoot; Sarah E Leyde; Theodore C White
Journal:  Microbiology       Date:  2008-03       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.